Absolute bioavailability of bromfenac in humans

Annals of Pharmacotherapy

Volumn 31, Issue 4, 1997, Pages 395-399

  Gumbhir Shah, Kavita ^a   Cevallos, William H ^b   DeCleene, Sheryl A ^b   Halstenson, Charles E ^c   Korth Bradley, Joan M ^a,b  

^a WYETH AYERST RESEARCH   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMFENAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANALGESIA; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; URINARY EXCRETION;

EID: 0030989577     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1177/106002809703100401     Document Type: Article

References (18)

1. Sancilio LF, Nolan JC, Wagner LE, Ward JW. The analgesic and antiinflammatory activity and pharmacologic properties of bromfenac. Arzneimittelforschung 1987;37:513-9.
2. McQuay HJ, Dawn C, Frankland T, Harvey M, Moore A. Bromfenac, acetaminophen, and placebo in orthopedic postoperative pain. Clin Pharmacol Ther 1990;47:760-6.
3. Forbes JA, Edquist IA, Smith FG, Schwartz MK, Beaver WT. Evaluation of bromfenac, aspirin, and ibuprofen in postoperative oral surgery pain. Pharmacotherapy 1991;11:64-70.
4. Forbes JA, Beaver WT, Jones KF, Edquist IA, Gongloff CM, Smith WK, et al. Analgesic efficacy of bromfenac, ibuprofen, and aspirin in postoperative oral surgery pain. Clin Pharmacol Ther 1992;51:343-52.
5. Nolan JC, Osman MA, Cheng LK, Sancilio LF. Bromfenac, a new nonsteroidal anti-inflammatory drug: relationship between the anti-inflammatory and analgesic activity and plasma drug levels in rodents. J Pharmacol Exp Ther 1990;254:104-8.
6. Carroll D, Frankland T, Nagle C, McQuay H. Oral bromfenac 10 and 25 mg compared with sublingual buprenorphine 0.2 and 0.4 mg for postoperative pain relief. Br J Anaesth 1993;71:814-7.
7. Boström ÅAS, Forbes JA, Adolfsson C, Beaver WT, Bell WE. Evaluation of bromfenac and ibuprofen for pain after orthopedic surgery. Pharmacotherapy 1994;14:305-13.
8. Mehlish DR, Fulmer RI. Double-blind, crossover comparison of bromfenac sodium, naproxen sodium, and placebo for relief of pain from primary dysmenorrhea (abstract). J Soc Gynecol Invest 1996;3:152A.
9. Wajdula JS, Vavra I, Sullivan D, Ermer J, Osman M. Bromfenac. In: Lewis AJ, Furst DE, eds. Nonsteroidal anti-inflammatory drugs: mechanisms and clinical uses. 2nd ed. New York: Marcel Dekker, Inc., 1994:267-84.
10. Geil S, Ermer J, DeCleene S, Cevallos W, Ben-Maimon C. Bromfenac single dose and steady-state dose proportionality. Pharm Res 1993;10 (suppl):S331.
11. Korth-Bradley JM, Cevallos WH, Ben-Maimon CS, Hicks DR, Chiang ST. The effects of age and gender on the pharmacokinetics of bromfenac in healthy volunteers. Pharm Res 1993;10(suppl):S104.
12. Ermer JC, Burghart P, Rudnick M, Cevallos W, Fruncillo R, Berns J, et al. The effect of renal disease on bromfenac disposition. Pharm Res 1993;10(suppl):S105.
13. Osman MA, Dunning LK, Cheng LK, Wright GJ. Determination of bromfenac in plasma by high-performance liquid chromatography. J Chromatogr 1989;489:452-8.
14. Gumbhir-Shah K, Cevallos WH, DeCleene SA, Korth-Bradley JM. Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis. J Rheumatol 1996;23:984-9.
15. Boudinot DF, Jusko WJ. Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. J Pharm Sci 1984;73:774-80.
16. Jusko WJ. Guidelines for collection and analysis of pharmacokinetic data. In: Evans WE, Schentag JJ, Jusko WJ, eds. Applied pharmacokinetics. Principles of therapeutic drug monitoring. 3rd ed. Spokane, WA: Applied Therapeutics, 1992:2-1-2-43.
17. PCNONLIN user's guide, version 4.0. Apex, NC: Scientific Consulting, Inc., 1992.
18. Osman M, Chandrasekaran A, Warsheski J, Chan K, Scatina J, Ermer J, et al. Metabolic disposition of bromfenac in healthy volunteers. Pharm Res 1995;12(suppl):S372.